Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast CancerT. M. Mohiuddin(Justus-Liebig-Universität Gießen), Ahmad Fawzi Hussain(Justus-Liebig-Universität Gießen)International Journal of Molecular SciencesAugust 1, 202510.3390/ijms26157430Cited by 3SaveCiteExport RISWatch citationsRelated PapersMolecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials|Cancers|2019|211Development of SNAP-Tag Based Nanobodies as Secondary Antibody Mimics for Indirect Immunofluorescence Assays|Cells|2025|5